Proactive Investors reported on Race Oncology's revised corporate strategy, designed to maximise the commercial potential…
15
Aug
Writing in The Australian, Stockhead reported on Race Oncology’s revised corporate strategy. They spoke to Race Oncology CEO and MD Damian Clarke-Bruce about how Race Oncology is working to put itself at the heart of cancer care. Read the full piece here.
